Onconetix, Inc. (ONCO)

0.1410 -0.0032 (-2.22%) At close: 04:00PM EDT

Onconetix, Inc.

201 East Fifth Street
Suite 1900
Cincinnati, OH 45202
United States
513 620 4101
https://onconetix.gcs-web.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 12

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Brian Price Ph.D.	Head of Technology Strategy	126.48k	N/A	N/A
Mr. Frank A. Jaeger M.A., M.B.A.	Senior VP of Marketing & Business Development	N/A	N/A	1970
Mr. Andrew D. Skibo Ph.D.	Global Head of Biologics Operations	N/A	N/A	N/A
Mr. Theodore Scott Yoho	Head of Business Development	N/A	N/A	N/A
Dr. Ali I. Fattom Ph.D.	Head of Science & Discovery	N/A	N/A	N/A
Dr. Jay Newmark M.B.A., M.D.	Chief Medical Officer	N/A	N/A	N/A
Mr. Christian Bruhlmann	Chief Strategy Officer & GM of Europe	N/A	N/A	1977
Dr. Donald L. Very Jr., Ph.D.	Senior VP of Commercial Research & Development	N/A	N/A	N/A

Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology. It offers Entadfi, an FDA-approved, once daily pill that combines finasteride and tadalafil for the treatment of benign prostatic hyperplasia; and Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was incorporated in 2018 and is headquartered in Cincinnati, Ohio.

Corporate governance

Onconetix, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.